Barinthus Biotherapeutics (BRNS) Other Non Operating Income (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Other Non Operating Income of $39000.0 for Q1 2026, down 48.0% on a YoY basis from $75000.0 in Q1 2025, and up 137.5% quarter-over-quarter from -$104000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Other Non Operating Income (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Other Non Operating Income for 7 years, with the latest figure at $39000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 48.0% year-over-year to $39000.0; the trailing twelve-month figure through Mar 2026 stood at -$20000.0 (down 109.52% YoY), and the FY2025 full-year result was $16000.0, down 88.15% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $39000.0, up from -$104000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $13.8 million in Q1 2022, with the low at -$275000.0 in Q3 2025.
- Historically, Other Non Operating Income has averaged $1.1 million across 5 years, with a median of $63000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1800.0% — and 2025, when it sank 1157.69%.
- Barinthus Biotherapeutics' Other Non Operating Income stood at $516000.0 in 2022, then jumped by 50.0% to $774000.0 in 2023, then sank by 88.5% to $89000.0 in 2024, then sank by 216.85% to -$104000.0 in 2025, then jumped by 137.5% to $39000.0 in 2026.
- The last three Other Non Operating Income figures came in at $39000.0 (Q1 2026), -$104000.0 (Q4 2025), and -$275000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Jun 30, 2025 | 320,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Dec 31, 2023 | 774,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 310,000.00 |
| Dec 31, 2022 | 516,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 13.79 Mn |
| Sep 30, 2021 | -19.78 Mn |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | 5.99 Mn |
| Dec 31, 2020 | -534,000.00 |
| Sep 30, 2020 | 3,000.00 |